Novanta (NASDAQ:NOVT) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

23 Feb 2026, 23:58 by Michael Walen · The Markets Daily

Novanta (NASDAQ:NOVT – Get Free Report) announced its quarterly earnings data on Monday. The technology company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.88 by $0.03, FiscalAI reports. The business had revenue of $258.35 million during the quarter, compared to analyst estimates of $260.72 million. Novanta had a return on equity of 14.53% and a net margin of 5.50%.

Novanta Trading Down 2.5%

NASDAQ NOVT traded down $3.58 on Monday, hitting $142.38. 625,403 shares of the stock were exchanged, compared to its average volume of 450,487. The company’s 50-day moving average price is $131.69 and its two-hundred day moving average price is $119.68. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.51 and a quick ratio of 1.54. Novanta has a 52-week low of $98.27 and a 52-week high of $153.20. The company has a market capitalization of $5.09 billion, a price-to-earnings ratio of 96.86 and a beta of 1.62.

Insider Buying and Selling at Novanta

In other Novanta news, CEO Matthijs Glastra sold 7,500 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $145.04, for a total transaction of $1,087,800.00. Following the completion of the sale, the chief executive officer directly owned 57,367 shares in the company, valued at approximately $8,320,509.68. This trade represents a 11.56% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Robert Buckley sold 1,423 shares of the company’s stock in a transaction dated Wednesday, January 21st. The shares were sold at an average price of $140.14, for a total value of $199,419.22. Following the completion of the transaction, the chief financial officer owned 91,034 shares in the company, valued at $12,757,504.76. This represents a 1.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 22,923 shares of company stock valued at $3,182,264. 1.20% of the stock is currently owned by insiders.

Institutional Trading of Novanta

Institutional investors have recently made changes to their positions in the stock. Schroder Investment Management Group lifted its stake in shares of Novanta by 206.1% in the fourth quarter. Schroder Investment Management Group now owns 600,146 shares of the technology company’s stock worth $72,540,000 after buying an additional 404,097 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC raised its holdings in Novanta by 217,908.2% in the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 346,633 shares of the technology company’s stock worth $41,246,000 after acquiring an additional 346,474 shares during the period. Wellington Management Group LLP raised its holdings in Novanta by 247.2% in the 4th quarter. Wellington Management Group LLP now owns 357,946 shares of the technology company’s stock worth $42,592,000 after acquiring an additional 254,860 shares during the period. American Capital Management Inc. acquired a new position in Novanta during the 3rd quarter worth $21,919,000. Finally, Bamco Inc. NY boosted its holdings in Novanta by 202.3% during the second quarter. Bamco Inc. NY now owns 311,115 shares of the technology company’s stock valued at $40,112,000 after acquiring an additional 208,188 shares during the period. 98.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have recently weighed in on NOVT. Zacks Research upgraded shares of Novanta from a “strong sell” rating to a “hold” rating in a research report on Friday, January 16th. Weiss Ratings upgraded shares of Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, January 20th. Three analysts have rated the stock with a Hold rating, According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $133.00.

Check Out Our Latest Research Report on Novanta

Novanta Company Profile

(Get Free Report)

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.